Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


INTERVIEW: Unravelling The Strategies Behind Sanofi's China Surge

This article was originally published in PharmAsia News

Executive Summary

The figures are screaming for attention. While many multinationals are grappling with lower single-digit growth in China, Sanofi logged a 20% increase last year, despite the country’s overall economic downturn. The figure was testament to the French group’s creative approaches to county-level opportunities and integrated disease management in a market filled with complexities and uncertainties. Sanofi Pharma China GM Jean-Christophe Pointeau shares some of the secrets in an exclusive interview.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts